当地洗剂模型的SNARE介导的膜融合模型
Josep Rizo1,2,3, Madhurima Chattopadhyay1,2,3, Aleksandra Wosztyl1,2,3
1Department of Biophysics, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
Journal of cell science
|January 22, 2026
概括
可溶性N-乙基胺敏感因子附着蛋白受体 (SNAREs) 可能不作为刚性棒,而是作为洗剂. 这种机制解释了SNARE如何催化膜内部混合,这对于生物膜融合至关重要.
科学领域:
- 分子生物学分子生物学
- 生物物理学的生物物理.
- 细胞生物学 细胞生物学
背景情况:
- 传统模型建议膜排斥作为主要的融合屏障.
- 据认为,可溶性N-乙基胺敏感因子附着蛋白受体 (SNAREs) 通过形成刚性螺旋结构来克服排斥.
研究的目的:
- 审查分子动力学模拟,建议用于膜融合的替代模型.
- 建议SNARE作为洗剂来促进疏水膜混合.
主要方法:
- 对最近的分子动力学模拟进行了审查.
- 对细胞-细胞和病毒-细胞融合蛋白的结构性质的分析.
主要成果:
- 膜内部的混合,而不是排斥,是主要的融合障碍.
- SNAREs可能作为局部洗剂来催化疏水混合.
- 这种SNARE促进了茎状结构和融合孔的形成.
结论:
- 一个新的模型表明,SNAREs充当洗剂,催化膜融合.
- 这种类似于洗剂的SNARE的功能可能是各种生物膜融合的通用机制.
相关概念视频
SNAREs and Membrane Fusion
12.5K
Once a transport vesicle has recognized its target organelle, the vesicular membrane needs to fuse with the target membrane to unload the cargo. Transmembrane proteins called SNAREs present on organelle membranes and their vesicles, mediate vesicle fusion.
SNAREs exist in pairs that symmetrically interact and catalyze the fusion of the lipid bilayers in vesicle and target organelle. v-SNARE in the vesicle membrane are single polypeptide chains that bind to a complementary t-SNARE, composed of 2...
SNAREs exist in pairs that symmetrically interact and catalyze the fusion of the lipid bilayers in vesicle and target organelle. v-SNARE in the vesicle membrane are single polypeptide chains that bind to a complementary t-SNARE, composed of 2...
12.5K
Detergent Purification of Membrane Proteins
6.3K
Detergents are used to purify the integral proteins of the membrane. The hydrophobic portion of the detergent can replace membrane phospholipids while solubilizing the membrane proteins. When detergent monomers reach a specific concentration in a solution called critical micelle concentration (CMC), they form micelles. Above CMC, the concentration of the detergent monomers remains in equilibrium with the micelle. The number of detergent monomers present in the CMC varies for each detergent, and...
6.3K
Fusion of Secretory Vesicles with the Plasma Membrane
16.6K
Proteins and neurotransmitters in secretory vesicles can be released from a cell upon vesicle docking, priming, and fusion with the plasma membrane. Vesicles are docked and primed in preparation for the quick exocytosis of their contents in response to a stimulus. The fusion process is mainly carried out by a SNAP Receptor or SNARE complex, consisting of synaptobrevin, syntaxin-1, and SNAP-25.
In 1993, Jim Rothman proposed that the antiparallel pairing of vesicular and transmembrane SNAREs, or...
In 1993, Jim Rothman proposed that the antiparallel pairing of vesicular and transmembrane SNAREs, or...
16.6K
Nuclear Fusion
33.7K
The process of converting very light nuclei into heavier nuclei is also accompanied by the conversion of mass into large amounts of energy, a process called fusion. The principal source of energy in the sun is a net fusion reaction in which four hydrogen nuclei fuse and ultimately produce one helium nucleus and two positrons.
A helium nucleus has a mass that is 0.7% less than that of four hydrogen nuclei; this lost mass is converted into energy during the fusion. This reaction produces about...
A helium nucleus has a mass that is 0.7% less than that of four hydrogen nuclei; this lost mass is converted into energy during the fusion. This reaction produces about...
33.7K
Receptor-mediated Endocytosis
110.6K
Overview
110.6K
Drug Absorption Mechanism: Carrier-Mediated Membrane Transport
5.9K
Certain large, lipid-insoluble drug molecules that resemble amino acids, peptides, or glucose, require specialized carrier proteins to facilitate their diffusion across cell membranes. This transport can occur through either facilitated diffusion, which does not require energy input, or active transport, which does require energy input.
Facilitated diffusion is a passive process that utilizes human Solute Carrier (SLC) transporters. These transporters bind to the drug, undergo structural...
Facilitated diffusion is a passive process that utilizes human Solute Carrier (SLC) transporters. These transporters bind to the drug, undergo structural...
5.9K


